Published in Am J Hum Genet on August 01, 1998
Commitment to X inactivation precedes the twinning event in monochorionic MZ twins. Am J Hum Genet (1998) 1.61
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr (1997) 2.92
Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature (1986) 2.76
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74
X inactivation in females with X-linked disease. N Engl J Med (1998) 2.67
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50
Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet (1996) 2.29
An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med (1999) 2.20
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood (2001) 2.15
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10
Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med (1996) 1.86
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74
Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest (1987) 1.67
Heterogeneity of clinical severity and molecular lesions in Aicardi syndrome. J Pediatr (1990) 1.62
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A (1999) 1.56
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood (2001) 1.55
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 1.42
Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol (1998) 1.41
Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci U S A (1988) 1.41
Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr (1988) 1.39
Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol (1997) 1.27
Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J Infect Dis (1985) 1.21
Delayed eruption of permanent teeth in hyperimmunoglobulinemia E recurrent infection syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 1.21
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol (2001) 1.20
An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family. Am J Hum Genet (2001) 1.18
Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome. Oral Dis (2008) 1.10
Dinucleotide repeat polymorphism at the DXS441 locus. Nucleic Acids Res (1992) 1.07
IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. Genomics (1994) 1.06
Regulatory interactions governing the proliferation of T cell subsets stimulated with pokeweed mitogen. J Immunol (1984) 1.00
Gene localization and syntenic mapping by FISH in the dog. Cytogenet Cell Genet (1996) 0.99
X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings. J Clin Invest (1990) 0.98
IL2RGbase: a database of gamma c-chain defects causing human X-SCID. Immunol Today (1996) 0.97
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr (1998) 0.96
Primary immunodeficiency mutation databases. Adv Genet (2001) 0.95
Sib understanding of genetics and attitudes toward carrier testing for X-linked severe combined immunodeficiency. Am J Med Genet (2001) 0.95
Molecular analysis of X-linked agammaglobulinemia with growth hormone deficiency. J Pediatr (1991) 0.94
Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy. Mol Ther (2000) 0.94
The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22. Genomics (1991) 0.93
Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J (1996) 0.92
Clonal analysis of solitary follicular nodules in the thyroid. Am J Pathol (1990) 0.90
Family pictures: growing up with a brother with X-linked severe combined immunodeficiency. Am J Med Genet (2001) 0.90
Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features. Radiology (1999) 0.89
X chromosome inactivation patterns in obligate carriers of X-linked lymphoproliferative syndrome. Clin Immunol Immunopathol (1990) 0.88
Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr (1999) 0.87
Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred. J Clin Immunol (1997) 0.87
Genomic structure and mapping of human FADD, an intracellular mediator of lymphocyte apoptosis. J Immunol (1996) 0.86
Intronic point mutation in the IL2RG gene causing X-linked severe combined immunodeficiency. Hum Mol Genet (1995) 0.84
The interleukin-4 receptor variant Q576R in hyper-IgE syndrome. N Engl J Med (1998) 0.84
Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Clin Immunol (1999) 0.83
Definition of the gene loci in X-linked immunodeficiencies. Immunol Invest (1988) 0.83
Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency. Clin Immunol (2000) 0.83
The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis. Clin Rev Allergy Immunol (2001) 0.82
Comparative mapping of canine and human proximal Xq and genetic analysis of canine X-linked severe combined immunodeficiency. Genomics (1994) 0.81
Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation. Genet Med (2001) 0.81
Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency. J Biol Chem (1997) 0.80
Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. Am J Hum Genet (1995) 0.80
RFLPs in human X-linked PGK1: a new probe for the PstI RFLP demonstrates strong linkage disequilibrium with the BgII RFLP. Nucleic Acids Res (1989) 0.78
Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin Infect Dis (1993) 0.78
Localization of the 75-kDa inositol polyphosphate-5-phosphatase (INPP5B) to human chromosome band 1p34. Cytogenet Cell Genet (1994) 0.78
Primary immunodeficiency diseases. JAMA (1997) 0.78
Twelve new polymorphic microsatellites on human chromosome 22. Genomics (1993) 0.78
Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. Blood (1996) 0.78
Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes. Blood (1998) 0.77
Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiency. Gene Ther (1998) 0.77
Interleukin-7R alpha mRNA expression increases as stem cells differentiate into T and B lymphocyte progenitors. Exp Hematol (1997) 0.77
Branhamella catarrhalis sepsis. Pediatr Infect Dis (1985) 0.76
A disease gene for autosomal hyper-IgM syndrome: more genes associated with more immunodeficiencies. Clin Immunol (2000) 0.75
The Canale-Smith syndrome. N Engl J Med (1997) 0.75
Antigen presentation to human T lymphocytes. I. Different requirements for stimulation by hapten-modified cells vs. cell sonicates. J Exp Med (1981) 0.75
Seven chromosome 22 STR polymorphisms. Hum Mol Genet (1994) 0.75
Antigen presentation to human T lymphocytes. II. Requirements for Mac-120+ macrophages and responsiveness to interleukin 2. Cell Immunol (1983) 0.75
Bromodeoxyuridine and light treatment enhances responsiveness of pokeweed mitogen-stimulated human lymphocytes to autologous and allogeneic determinants. Cell Immunol (1982) 0.75
Lymphocyte subsets in patients with acquired immunodeficiency syndrome (AIDS), aids-related complex (ARC), and acute viral infections. Trans Assoc Am Physicians (1984) 0.75
Canine lymphocyte expression of retrovirally transferred human common gamma chain. Ann N Y Acad Sci (1999) 0.75
Immunodeficiencies: injecting some safety into SCID gene therapy? Gene Ther (2006) 0.75
Genetic testing and screening in pediatric populations. Nurs Clin North Am (2000) 0.75
Role of Ia-positive cells in induction of secondary human immune responses to haptens in vitro. J Exp Med (1980) 0.75